版本:
中国

BRIEF-Intercept Pharmaceuticals files new drug submission to Health Canada

Sept 19 Intercept Pharmaceuticals Inc :

* Intercept Pharmaceuticals files new drug submission to Health Canada for marketing approval of obeticholic acid for the treatment of patients with primary biliary cholangitis Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐